癌症研究档案

  • 国际标准期刊号: 2254-6081
  • 期刊 h 指数: 13
  • 期刊引用分数: 3.58
  • 期刊影响因子: 3.12
索引于
  • 中国知网(CNKI)
  • 引用因子
  • OCLC-WorldCat
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • 秘密搜索引擎实验室
分享此页面

抽象的

Exosomes produced from cancer cells' genomic and proteomic composition

Shifa Saeed

Exosomes produced by tumours (called tumor-derived exosomes, or TDEs) are involved in the initiation and development of several cancerous processes, such as tumour microenvironment (TME) remodelling, angiogenesis, invasion, metastasis, and drug resistance. Exosomes deliver diverse payloads to destination cells, where they activate or inhibit multiple signalling pathways. We go through exosome biosynthesis, exosome-mediated metastasis, and chemoresistance in this review. The involvement of tumor-derived exosomes in angiogenesis and the remodelling of the tumour microenvironment are also discussed. Additionally, epithelial mesenchymal transition (EMT) exosome induction is underlined. More significantly, we go into great detail on how exosomes control treatment resistance in various malignancies. In order to develop new therapeutic approaches for cancer progression, particularly to overcome therapy-resistance and prevent metastasis as major factors of cancer mortality, it may be helpful to understand exosome biogenesis, their contents, and the molecular mechanisms and signalling pathways that are responsible for metastasis and drug- resistance mediated by TDEs

Keywords

Exosomes; Drug-resistance; Cancer progression; Metastasis; Multivesicular bodies

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证